nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP7—gall bladder—pancreatic cancer	0.0381	0.197	CbGeAlD
Doxycycline—MMP7—islet of Langerhans—pancreatic cancer	0.025	0.129	CbGeAlD
Doxycycline—MMP1—islet of Langerhans—pancreatic cancer	0.022	0.114	CbGeAlD
Doxycycline—MMP13—digestive system—pancreatic cancer	0.0188	0.0976	CbGeAlD
Doxycycline—MMP7—pancreas—pancreatic cancer	0.0176	0.091	CbGeAlD
Doxycycline—MMP8—digestive system—pancreatic cancer	0.017	0.088	CbGeAlD
Doxycycline—MMP1—pancreas—pancreatic cancer	0.0155	0.0803	CbGeAlD
Doxycycline—MMP7—digestive system—pancreatic cancer	0.015	0.0777	CbGeAlD
Doxycycline—MMP1—digestive system—pancreatic cancer	0.0132	0.0686	CbGeAlD
Doxycycline—Minocycline—CASP3—pancreatic cancer	0.0121	0.523	CrCbGaD
Doxycycline—SLC22A11—digestive system—pancreatic cancer	0.00839	0.0435	CbGeAlD
Doxycycline—Minocycline—VEGFA—pancreatic cancer	0.00563	0.243	CrCbGaD
Doxycycline—Minocycline—MMP9—pancreatic cancer	0.00545	0.235	CrCbGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—NFKBIA—pancreatic cancer	0.0031	0.00396	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CXCL8—pancreatic cancer	0.00309	0.00394	CbGpPWpGaD
Doxycycline—MMP13—Collagen degradation—MMP9—pancreatic cancer	0.00308	0.00392	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—NFKBIA—pancreatic cancer	0.00307	0.00391	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—PRSS1—pancreatic cancer	0.00301	0.00384	CbGpPWpGaD
Doxycycline—MMP7—Collagen degradation—MMP9—pancreatic cancer	0.00297	0.00379	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—MMP9—pancreatic cancer	0.00297	0.00379	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—NFKBIA—pancreatic cancer	0.00296	0.00378	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—pancreatic cancer	0.00296	0.00377	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CDH1—pancreatic cancer	0.00295	0.00376	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AHR—pancreatic cancer	0.00295	0.00376	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—RB1—pancreatic cancer	0.00293	0.00374	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—CD44—pancreatic cancer	0.00291	0.00372	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—CCND1—pancreatic cancer	0.00288	0.00367	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—MMP9—pancreatic cancer	0.00287	0.00366	CbGpPWpGaD
Doxycycline—MMP13—Matrix Metalloproteinases—TNF—pancreatic cancer	0.00286	0.00365	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP2—pancreatic cancer	0.00284	0.00362	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—MMP9—pancreatic cancer	0.00284	0.00362	CbGpPWpGaD
Doxycycline—MMP7—Matrix Metalloproteinases—TNF—pancreatic cancer	0.00276	0.00352	CbGpPWpGaD
Doxycycline—MMP1—Activation of Matrix Metalloproteinases—MMP9—pancreatic cancer	0.00273	0.00348	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00269	0.00344	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CXCL8—pancreatic cancer	0.00268	0.00342	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HIF1A—pancreatic cancer	0.00263	0.00336	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP2—pancreatic cancer	0.00263	0.00336	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—SRC—pancreatic cancer	0.00262	0.00334	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CASP3—pancreatic cancer	0.00261	0.00333	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP2—pancreatic cancer	0.00254	0.00324	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—CTNNB1—pancreatic cancer	0.00251	0.00321	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—VEGFA—pancreatic cancer	0.00251	0.0032	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CCND1—pancreatic cancer	0.0025	0.00319	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—HIF1A—pancreatic cancer	0.00248	0.00317	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PLAU—pancreatic cancer	0.00246	0.00314	CbGpPWpGaD
Doxycycline—MMP7—Syndecan-1-mediated signaling events—TGFB1—pancreatic cancer	0.00245	0.00312	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—MMP9—pancreatic cancer	0.00243	0.0031	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—NFKBIA—pancreatic cancer	0.0024	0.00306	CbGpPWpGaD
Doxycycline—MMP13—Assembly of collagen fibrils and other multimeric structures—MMP9—pancreatic cancer	0.00239	0.00305	CbGpPWpGaD
Doxycycline—MMP1—Collagen degradation—MMP9—pancreatic cancer	0.00238	0.00303	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—MMP9—pancreatic cancer	0.00238	0.00303	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CD44—pancreatic cancer	0.00236	0.00301	CbGpPWpGaD
Doxycycline—CYP3A4—digestive system—pancreatic cancer	0.00235	0.0122	CbGeAlD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—TGFB1—pancreatic cancer	0.00234	0.00299	CbGpPWpGaD
Doxycycline—MMP7—Assembly of collagen fibrils and other multimeric structures—MMP9—pancreatic cancer	0.00231	0.00295	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—MYC—pancreatic cancer	0.00231	0.00295	CbGpPWpGaD
Doxycycline—MMP13—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—pancreatic cancer	0.00229	0.00293	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—PLAU—pancreatic cancer	0.00228	0.0029	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—SRC—pancreatic cancer	0.00227	0.0029	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—EGFR—pancreatic cancer	0.00226	0.00288	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—CASP3—pancreatic cancer	0.00226	0.00288	CbGpPWpGaD
Doxycycline—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00224	0.00286	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—CASP3—pancreatic cancer	0.00224	0.00285	CbGpPWpGaD
Doxycycline—MMP1—Matrix Metalloproteinases—TNF—pancreatic cancer	0.00221	0.00282	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—GADD45A—pancreatic cancer	0.00219	0.00279	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CDH1—pancreatic cancer	0.00215	0.00274	CbGpPWpGaD
Doxycycline—MMP8—Degradation of the extracellular matrix—MMP9—pancreatic cancer	0.00213	0.00272	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—CASP3—pancreatic cancer	0.00212	0.0027	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—PTEN—pancreatic cancer	0.0021	0.00268	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—CASP3—pancreatic cancer	0.00209	0.00267	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CDH1—pancreatic cancer	0.00208	0.00265	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP2—pancreatic cancer	0.00207	0.00264	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00205	0.00262	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—MMP9—pancreatic cancer	0.00203	0.00259	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—CASP3—pancreatic cancer	0.00202	0.00258	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP2—pancreatic cancer	0.002	0.00255	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—EGFR—pancreatic cancer	0.00199	0.00254	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MMP9—pancreatic cancer	0.00198	0.00252	CbGpPWpGaD
Doxycycline—MMP1—Syndecan-1-mediated signaling events—TGFB1—pancreatic cancer	0.00196	0.0025	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—CASP3—pancreatic cancer	0.00195	0.00249	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MMP9—pancreatic cancer	0.00191	0.00244	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—TP53—pancreatic cancer	0.0019	0.00242	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—STK11—pancreatic cancer	0.00187	0.00239	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—FUT8—pancreatic cancer	0.00186	0.00237	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—SRC—pancreatic cancer	0.00185	0.00235	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SMAD4—pancreatic cancer	0.00183	0.00233	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—SRC—pancreatic cancer	0.00182	0.00233	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—VEGFA—pancreatic cancer	0.00182	0.00232	CbGpPWpGaD
Doxycycline—MMP1—Bladder Cancer—HRAS—pancreatic cancer	0.00181	0.00231	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—VEGFA—pancreatic cancer	0.0018	0.00229	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—STAT3—pancreatic cancer	0.00178	0.00227	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CDKN2A—pancreatic cancer	0.00178	0.00227	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—SRC—pancreatic cancer	0.00176	0.00225	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—STAT3—pancreatic cancer	0.00176	0.00224	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—MYC—pancreatic cancer	0.00175	0.00223	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CD44—pancreatic cancer	0.00172	0.0022	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.00171	0.00219	CbGpPWpGaD
Doxycycline—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00171	0.00218	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—STAT3—pancreatic cancer	0.0017	0.00217	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—BRCA2—pancreatic cancer	0.00169	0.00216	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00168	0.00214	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—pancreatic cancer	0.00167	0.00213	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CD44—pancreatic cancer	0.00166	0.00212	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CDH1—pancreatic cancer	0.00166	0.00212	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—CASP3—pancreatic cancer	0.00165	0.0021	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—SMAD4—pancreatic cancer	0.00164	0.00209	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—CASP3—pancreatic cancer	0.00164	0.00209	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—pancreatic cancer	0.00163	0.00208	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—pancreatic cancer	0.00161	0.00205	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—pancreatic cancer	0.0016	0.00204	CbGpPWpGaD
Doxycycline—MMP7—Posttranslational regulation of adherens junction stability and dissassembly—HRAS—pancreatic cancer	0.0016	0.00204	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—EGFR—pancreatic cancer	0.0016	0.00204	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—CASP3—pancreatic cancer	0.00159	0.00203	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—pancreatic cancer	0.00158	0.00201	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TERT—pancreatic cancer	0.00156	0.00199	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—pancreatic cancer	0.00156	0.00199	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—EGFR—pancreatic cancer	0.00154	0.00197	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—KRAS—pancreatic cancer	0.00153	0.00195	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—pancreatic cancer	0.0015	0.00192	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CCND1—pancreatic cancer	0.0015	0.00191	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—CTNNB1—pancreatic cancer	0.00149	0.0019	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—SRC—pancreatic cancer	0.00146	0.00186	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—KDR—pancreatic cancer	0.00146	0.00186	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—pancreatic cancer	0.00146	0.00186	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—PTEN—pancreatic cancer	0.00145	0.00185	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—TP53—pancreatic cancer	0.00143	0.00183	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—SRC—pancreatic cancer	0.00143	0.00182	CbGpPWpGaD
Doxycycline—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A2—pancreatic cancer	0.00143	0.00182	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—pancreatic cancer	0.00142	0.00181	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MET—pancreatic cancer	0.0014	0.00178	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IFNA5—pancreatic cancer	0.0014	0.00178	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CCND1—pancreatic cancer	0.00139	0.00177	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—pancreatic cancer	0.00139	0.00177	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—CTNNB1—pancreatic cancer	0.00138	0.00175	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—STAT3—pancreatic cancer	0.00137	0.00175	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00137	0.00175	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—TP53—pancreatic cancer	0.00136	0.00173	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TSC2—pancreatic cancer	0.00134	0.00171	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CD44—pancreatic cancer	0.00133	0.0017	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PPP2R5B—pancreatic cancer	0.00132	0.00168	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—HRAS—pancreatic cancer	0.0013	0.00166	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—PIK3CA—pancreatic cancer	0.00129	0.00165	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00128	0.00163	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—CASP3—pancreatic cancer	0.00127	0.00162	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CB—pancreatic cancer	0.00127	0.00162	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—TP53—pancreatic cancer	0.00125	0.0016	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CDH1—pancreatic cancer	0.00124	0.00158	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—AKT1—pancreatic cancer	0.00121	0.00154	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MYC—pancreatic cancer	0.0012	0.00154	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—pancreatic cancer	0.0012	0.00153	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—pancreatic cancer	0.0012	0.00153	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—pancreatic cancer	0.00119	0.00152	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—KRAS—pancreatic cancer	0.00118	0.00151	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—AKT1—pancreatic cancer	0.00116	0.00148	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—AKT1—pancreatic cancer	0.00115	0.00146	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PCSK1—pancreatic cancer	0.00113	0.00145	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—AKT1—pancreatic cancer	0.00113	0.00145	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—MYC—pancreatic cancer	0.00111	0.00142	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AKT1—pancreatic cancer	0.00109	0.0014	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—RB1—pancreatic cancer	0.00109	0.00139	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CDH1—pancreatic cancer	0.00109	0.00139	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.00107	0.00136	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—KDR—pancreatic cancer	0.00106	0.00136	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—AKT1—pancreatic cancer	0.00106	0.00135	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—TP53—pancreatic cancer	0.00105	0.00134	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.00104	0.00133	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PPP2R5B—pancreatic cancer	0.00104	0.00132	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—HRAS—pancreatic cancer	0.00103	0.00131	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—KDR—pancreatic cancer	0.00103	0.00131	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—SRC—pancreatic cancer	0.00102	0.0013	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.00102	0.0013	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—HRAS—pancreatic cancer	0.001	0.00128	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TP53—pancreatic cancer	0.000989	0.00126	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—NRAS—pancreatic cancer	0.000979	0.00125	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—CASP3—pancreatic cancer	0.000946	0.00121	CbGpPWpGaD
Doxycycline—MMP7—Wnt Signaling Pathway and Pluripotency—TP53—pancreatic cancer	0.000915	0.00117	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—AKT1—pancreatic cancer	0.000908	0.00116	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CCND1—pancreatic cancer	0.000903	0.00115	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CDH1—pancreatic cancer	0.000902	0.00115	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—pancreatic cancer	0.000894	0.00114	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—AKT1—pancreatic cancer	0.000886	0.00113	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000871	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—TP53—pancreatic cancer	0.000871	0.00111	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CDH1—pancreatic cancer	0.000871	0.00111	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—pancreatic cancer	0.000868	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—KRAS—pancreatic cancer	0.000843	0.00108	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—pancreatic cancer	0.000838	0.00107	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CASP3—pancreatic cancer	0.000834	0.00106	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—KDR—pancreatic cancer	0.000821	0.00105	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CCND1—pancreatic cancer	0.000811	0.00103	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—SRC—pancreatic cancer	0.000809	0.00103	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—CTNNB1—pancreatic cancer	0.000803	0.00102	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CD44—pancreatic cancer	0.00079	0.00101	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—PTEN—pancreatic cancer	0.000783	0.000999	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000776	0.00099	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—PIK3CA—pancreatic cancer	0.000774	0.000988	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IFNA1—pancreatic cancer	0.000765	0.000976	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—pancreatic cancer	0.000737	0.00094	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—AKT1—pancreatic cancer	0.000736	0.000938	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MYC—pancreatic cancer	0.000725	0.000924	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—pancreatic cancer	0.000723	0.000922	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—HRAS—pancreatic cancer	0.000716	0.000914	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IFNA2—pancreatic cancer	0.000712	0.000908	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—pancreatic cancer	0.000707	0.000902	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CDH1—pancreatic cancer	0.000696	0.000888	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—CASP3—pancreatic cancer	0.00069	0.000881	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—pancreatic cancer	0.00067	0.000855	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—CASP3—pancreatic cancer	0.000667	0.000851	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—pancreatic cancer	0.000652	0.000832	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—MYC—pancreatic cancer	0.000651	0.00083	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000648	0.000826	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—EGFR—pancreatic cancer	0.000637	0.000812	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—pancreatic cancer	0.00063	0.000804	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—KRAS—pancreatic cancer	0.000601	0.000767	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—GCG—pancreatic cancer	0.000596	0.00076	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TP53—pancreatic cancer	0.000595	0.000759	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—pancreatic cancer	0.000538	0.000686	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—TP53—pancreatic cancer	0.000534	0.000682	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—CASP3—pancreatic cancer	0.000533	0.00068	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—pancreatic cancer	0.000519	0.000663	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000517	0.00066	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAU—pancreatic cancer	0.000505	0.000644	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—pancreatic cancer	0.000504	0.000643	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—AKT1—pancreatic cancer	0.000503	0.000641	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AKT1—pancreatic cancer	0.000451	0.000576	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CG—pancreatic cancer	0.000449	0.000573	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—EGF—pancreatic cancer	0.000444	0.000567	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—pancreatic cancer	0.000415	0.00053	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CD—pancreatic cancer	0.000395	0.000504	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000394	0.000503	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—pancreatic cancer	0.000394	0.000502	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CB—pancreatic cancer	0.000344	0.000439	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	0.000329	0.00042	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—pancreatic cancer	0.000313	0.0004	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SRC—pancreatic cancer	0.000276	0.000352	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—pancreatic cancer	0.000269	0.000343	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NRAS—pancreatic cancer	0.000266	0.000339	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—pancreatic cancer	0.00026	0.000332	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—pancreatic cancer	0.000247	0.000315	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CTNNB1—pancreatic cancer	0.00024	0.000306	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KRAS—pancreatic cancer	0.000229	0.000292	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CA—pancreatic cancer	0.00021	0.000268	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TP53—pancreatic cancer	0.000203	0.000259	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—HRAS—pancreatic cancer	0.000194	0.000248	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—AKT1—pancreatic cancer	0.000172	0.000219	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PRSS1—pancreatic cancer	7.58e-05	9.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ARG2—pancreatic cancer	6.58e-05	8.39e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMP—pancreatic cancer	5.75e-05	7.33e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GLP1R—pancreatic cancer	4.63e-05	5.91e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—DPYD—pancreatic cancer	4.56e-05	5.81e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SLC2A2—pancreatic cancer	4.33e-05	5.52e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CD44—pancreatic cancer	3.35e-05	4.27e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GCG—pancreatic cancer	3.21e-05	4.1e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—STK11—pancreatic cancer	3.02e-05	3.85e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—TYMS—pancreatic cancer	2.6e-05	3.31e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOE—pancreatic cancer	2.11e-05	2.69e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CG—pancreatic cancer	1.91e-05	2.43e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—pancreatic cancer	1.84e-05	2.35e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CD—pancreatic cancer	1.68e-05	2.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CB—pancreatic cancer	1.46e-05	1.86e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—pancreatic cancer	1.45e-05	1.85e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTEN—pancreatic cancer	1.26e-05	1.61e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CA—pancreatic cancer	8.9e-06	1.14e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKT1—pancreatic cancer	7.27e-06	9.28e-06	CbGpPWpGaD
